Amanta Healthcare Ltd

Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Amanta Healthcare’s recent market assessment reflects a nuanced picture shaped by its financial performance, valuation metrics, and technical indicators. The pharmaceutical company’s long-term sales trajectory, debt servicing capacity, and return ratios have influenced a revision in its evaluation, highlighting both challenges and areas of relative strength within a competitive sector.

Amanta Healthcare, a player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in its business fundamentals as reflected in recent evaluation adjustments. Key financial metrics such as return on equity, return on capital employed, debt levels, and growth indicators reveal a nuanced picture of the company’s operational and financial health amid a challenging market environment.